Sirona Biochem Corp V.SBM

Alternate Symbol(s): SRBCF

Healthcare Biotechnology

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.

TSXV:SBM - Post by User

Sirona Biochem Corp

Bullboard Posts

Post by Haidukon Nov 26, 2015 5:16am

295 Views

Post# 24327123

"News" via Stockwatch... Interesting Exercise Price...

Sirona Biochem grants options to buy 1.2 million shares

2015-11-25 20:38 ET - News Release

Mr. Christopher Hopton reports

Sirona Biochem Grants Stock Options

Sirona Biochem Corp. has granted incentive stock options under its stock option plan to directors and officers of the company for the purchase of up to 1.2 million common shares at a price of 19 cents per share for a period of two years.

Via https://www.stockwatch.com/News/Item.aspx?bid=Z-C:SBM-2328940&symbol=SBM&region=C

Bullboard Posts

Rig Count Soars as Utilization Surpasses Industry Averages